SALIXIN A/S: Financial statements 2021
CVR: 33776748
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 9,103,319 and a net result of DKK 6,344,740 compared with DKK -746,288 the year before. That is an increase of 12,847.8% compared with the year before. Equity in the 2021 report amounted to DKK 3,895,372. The solvency ratio was 39.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 9,103,319
- Profit/Loss
- DKK 6,344,740
- Equity
- DKK 3,895,372
- Total Assets
- DKK 9,824,726
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 9.1M | 6.3M | 3.9M | 2 |
| 2020 | - | 70K | -746K | -2.4M | 2 |
| 2019 | - | -5K | -889K | -1.7M | 2 |
| 2018 | - | -235K | -974K | -814K | 2 |
| 2017 | - | -417K | -627K | 160K | 1 |
Official annual report
Find more companies like SALIXIN A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 9, 2021, Henrik Lyngsø Bach has joined the board of directors of SALIXIN A/S.
As of November 9, 2021, Andreas Ydesen has joined the board of directors of SALIXIN A/S.
As of November 9, 2021, Søren Fisker has left the board of directors of SALIXIN A/S.
As of November 9, 2021, Aage Bay Bach has left the board of directors of SALIXIN A/S.
As of November 9, 2021, Henrik Lyngsø Bach is registered as director of SALIXIN A/S.
As of November 9, 2021, Søren Fisker has stepped down as director of SALIXIN A/S.
As of November 8, 2021, Henrik Lyngsø Bach has left the board of directors of SALIXIN A/S.
SALIXIN A/S has published its annual report for 2020. Gross profit came to DKK 70,308, and the net result was DKK -746,288.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.